Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7494 p327
22 March 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Released prisoners exempt from charges

John Stillwell/PA

Prison

Released prisoners qualify for charge exemption on low income grounds

In the first phase of a national roll-out, all FP10 and FP10MDA prescriptions issued byselected prisons from 1 April 2008 will be exempt from prescription charges in England, providing certain conditions are met.

This follows changes to the NHS charges Regulations, guidance on which was published last week by the Department of Health.

To qualify for exemption from charges, prescriptions must be stamped with the letters “HMP” along with the issuing prison’s name, address and telephone switchboard number printed in the practice address box (the addition of handwritten “HMP” is not acceptable).

Patients are not required to sign the prescription to claim entitlement to exemption, although good practice guidance, such as that relating to Schedule 2 or 3 Controlled Drugs, still applies.

The prescriptions do not need to be separately bundled and should be submitted to the Prescription Pricing Division in the no-charge group.

The Pharmaceutical Services Negotiating Committee said this week that it would monitor how these prescriptions are handled by the PPD. It also said that guidance issued to prisons should ensure that, in most cases, pharmacies would be contacted in advance of a patient presenting a prison prescri tion.

Pharmacists can confirm the legitimacy of prescriptions (including the identity of the released prisoner) and the prescriber by contacting the healthcare manager at the prison stated on the form.

The PSNC plans to list contact details on its website for the six prisons involved as initial pathfinder sites. The DoH expects the programme to be extended to other prisons in England within a year.

Back to Top


©The Pharmaceutical Journal